Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Kedudukan dalam Saham #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Harga Saham
$2.49
Modal Pasaran
$4.47M
Perubahan (1 hari)
-4.01%
Perubahan (1 tahun)
678.16%
Negara
MY
Perdagangan BioNexus Gene Lab Corporation (BGLC)

Kategori

Nisbah P/B bagi BioNexus Gene Lab Corporation (BGLC)
Nisbah P/B pada March 2026 TTM: 0.59
Menurut laporan kewangan dan harga saham terkini BioNexus Gene Lab Corporation, nisbah P/B semasa (TTM) ialah 0.59. Pada akhir 2023, nisbah P/B syarikat ialah 0.95.
Sejarah nisbah P/B untuk BioNexus Gene Lab Corporation dari 2016 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US